Decay-accelerating factor

From Food & Medicine Encyclopedia

Decay-accelerating factor (DAF), also known as CD55 or Cromer blood group system, is a protein that in humans is encoded by the CD55 gene. DAF regulates the complement system on the cell surface to prevent the assembly of the complement membrane attack complex (MAC) on host cells.

Function[edit]

Decay-accelerating factor is involved in the regulation of the complement cascade. It protects cells from complement-mediated injury by inhibiting the C3 convertases, C4b2a and C3bBb, and by disrupting the function of these convertases.

Clinical significance[edit]

Deficiency of DAF can lead to paroxysmal nocturnal hemoglobinuria (PNH), a rare, acquired, potentially life-threatening disease of the blood characterized by complement-mediated intravascular hemolysis.

Interactions[edit]

Decay-accelerating factor has been shown to interact with Complement component 3 and Complement component 4b.

See also[edit]

References[edit]

<references />

External links[edit]

Stub icon

This medical article is a stub. You can help WikiMD by expanding the page.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=Decay-accelerating_factor&oldid=6527896"